2026 outlook -- EBITDA -- Full-year EBITDA guidance is $2.05 billion to $2.15 billion, representing 3%-8% comparable currency-neutral growth; productivity and efficiency gains are expected to fund ...
TransCon Growth Hormone or TransCon hGH is now approved in the US by the FDA for the replacement of endogenous growth hormone ...
Additional information concerning factors that could cause actual results to materially differ from those in our ...
Key Strategic Drivers: 3D EXPERIENCE software revenue increased by 10%, representing 41% of 3D EXPERIENCE Eligible software revenue. Cloud software revenue grew 8% in non-IFRS (7% in IFRS), and ...
Abstract: The increasing prevalence of extreme weather events and grid disruptions have amplified the need for resiliency in energy systems. Microgrid emerges as a pivotal solution for such a need.
Management reported that "meaningful" open bids were both awarded and lost during recent contract cycles, citing a strict focus on profitability and a readiness to capitalize on service failures by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results